Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q1 2024 (March 31)9holders
$19.13avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings. The largest holders were Todd Asset Management LLC ($3.6M), Confluence Investment Management LLC ($741K) and Rhumbline Advisers ($519K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $741K |
| Exits | 1 | $25K |
Ownership 9 holders
| Todd Asset Management LLC | 0.07% | Reduce -14.6% | 187,755 | $3.6M |
| Confluence Investment Management LLC | 0.01% | New | 38,730 | $741K |
| Rhumbline Advisers | 0.00% | Add +19.0% | 27,136 | $519K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -0.4% | 19,233 | $368K |
| Riverbridge Partners LLC | 0.00% | No change | 13,200 | $253K |
| GAMMA Investing LLC | 0.02% | Add +14.8% | 6,337 | $121K |
| Operose Advisors LLC | 0.00% | No change | 535 | $10K |
| Accent Capital Management, LLC | 0.01% | No change | 400 | $8K |
| Richardson Financial Services Inc. | 0.00% | New | 14 | $268 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.